
Henry Schein company profile
$86.22+0.09%Close 13 Nov 2026 · Market value $9.29B
About Henry Schein
Henry Schein distributes health care products and provides value-added services to the dental and medical markets. Its Global Distribution and Value-Added Services segment supplies national brand and corporate brand merchandise, equipment and related technical services to customers including dental practices, laboratories, physician practices, ambulatory surgery centers, government and institutional clinics, and home health providers. The company also offers practice management and other software for dental customers, homecare medical products delivered to patients, and manufactures dental implant, endodontic and orthopedic products. It markets its products in approximately 90 countries and operates distribution centers and manufacturing facilities around the world.
A summary of the business section of the company's latest annual report, filed 24 Feb 2026.
Company facts
| Ticker | HSIC · Nasdaq |
|---|
| Sector | Distribution |
|---|
| Industry | Health Care Distributors |
|---|
| Index | S&P 500 |
|---|
| Fiscal year ends | 27 December |
|---|
| Reporting currency | USD |
|---|
| CIK | 1000228 |
|---|
| Latest annual report | 10-K, filed 24 Feb 2026 |
|---|
Officers and directors
| Name | Role | Shares owned | Latest Form 4 |
|---|
| Stanley M. Bergman | Former Director | 575K · 0.5% | Gift, 26 May 2026 |
|---|
| Mark E. Mlotek | EVP, Chief Strategic Officer | 67.1K · < 1% | Shares withheld for tax, 16 Mar 2026 |
|---|
| Michael S. Ettinger | EVP & Chief Operating Officer | 64.1K · < 1% | Gift, 17 Mar 2026 |
|---|
| Philip A. Laskawy | Director | 58.6K · < 1% | Grant or award, 6 Mar 2026 |
|---|
| Bradley T. Sheares, Ph.D. | Director | 45.0K · < 1% | Grant or award, 6 Mar 2026 |
|---|
| Ronald N. South | SVP & Chief Financial Officer | 38.6K · < 1% | Shares withheld for tax, 16 Mar 2026 |
|---|
| Anne H. Margulies | Director | 27.8K · < 1% | Grant or award, 6 Mar 2026 |
|---|
| Joseph L. Herring | Director | 27.7K · < 1% | Grant or award, 6 Mar 2026 |
|---|
| Andrea Albertini | CEO, Global Dist. & Tech. | 26.6K · < 1% | Shares withheld for tax, 8 Sep 2026 |
|---|
| Mohamad Ali | Director | 13.7K · < 1% | Grant or award, 6 Mar 2026 |
|---|
| Deborah Derby | Director | 13.3K · < 1% | Grant or award, 6 Mar 2026 |
|---|
| Kurt P. Kuehn | Director | 12.8K · < 1% | Open-market sale, 10 Mar 2026 |
|---|
| William K. “Dan” Daniel | Director | 10.0K · < 1% | Grant or award, 12 Jun 2026 |
|---|
| Scott Serota | Director | 9.2K · < 1% | Grant or award, 6 Mar 2026 |
|---|
| Carole T. Faig | Director | 5.4K · < 1% | Grant or award, 6 Mar 2026 |
|---|
| Robert J. Hombach | Director | 2.8K · < 1% | Grant or award, 6 Mar 2026 |
|---|
| Frederick M. Lowery | CEO · Director | 0 · < 1% | Grant or award, 6 Mar 2026 |
|---|
| Popeck Thomas C | CEO, Henry Schein Products | — | Open-market sale, 19 Mar 2026 |
|---|
| Sheehy Christine Zayac | SVP, Chief Human Res. Officer | — | Shares withheld for tax, 16 Mar 2026 |
|---|
| Tuckson Reed Vaughn | Director | — | Grant or award, 6 Mar 2026 |
|---|
Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.
HSIC in the terminal
The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.